Gutiérrez, I.L.; Dello Russo, C.; Novellino, F.; Caso, J.R.; GarcÃa-Bueno, B.; Leza, J.C.; Madrigal, J.L.M.
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target. Int. J. Mol. Sci. 2022, 23, 6143.
https://doi.org/10.3390/ijms23116143
AMA Style
Gutiérrez IL, Dello Russo C, Novellino F, Caso JR, GarcÃa-Bueno B, Leza JC, Madrigal JLM.
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target. International Journal of Molecular Sciences. 2022; 23(11):6143.
https://doi.org/10.3390/ijms23116143
Chicago/Turabian Style
Gutiérrez, Irene L., Cinzia Dello Russo, Fabiana Novellino, Javier R. Caso, Borja GarcÃa-Bueno, Juan C. Leza, and José L. M. Madrigal.
2022. "Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target" International Journal of Molecular Sciences 23, no. 11: 6143.
https://doi.org/10.3390/ijms23116143
APA Style
Gutiérrez, I. L., Dello Russo, C., Novellino, F., Caso, J. R., GarcÃa-Bueno, B., Leza, J. C., & Madrigal, J. L. M.
(2022). Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target. International Journal of Molecular Sciences, 23(11), 6143.
https://doi.org/10.3390/ijms23116143